User login
Addressing Barriers to Cancer Care: An Interdisciplinary Team Approach to Patient Navigation (FULL)
Purpose: Create a custom patient navigation model and standard assessment tools that support an interdisciplinary team approach to address barriers to care for Veterans with cancer.
Background: Patient navigation is utilized throughout the country to address barriers to care in the most vulnerable of populations. A community needs assessment was conducted at the VA Puget Sound Health Care System in December 2014 to identify high-risk cohorts and facility barriers to care to drive the VA Puget Sound navigation team process. Veterans in identified cohorts thought to be at highest risk for barriers to care are enrolled in navigation services. Veterans are identified through formal consult, case finding and self-referral. The VA Puget Sound uses an interdisciplinary team approach that has been found to be successful in addressing complex barriers to cancer care. The VA Puget Sound Healthcare System Cancer Care Navigation Team (CCNT) consists of a Nurse Practitioner, Registered Nurse, Social Worker and a Medical Support Assistant who work together to fully address a wide range of physical, psychological and practical barriers to care that patients may experience throughout the cancer care continuum.
Methods: The CCNT uses standardized assessment tools, including a navigation intake form, the National Comprehensive Network (NCCN) Distress Thermometer and a functional assessment. The VA Puget Sound cancer navigation model is divided into four main processes based on the
cancer care continuum.
Results: Since initiation of the program in December of 2014, CCNT has enrolled over 1,295 patients diagnosed with cancer sites including: 291 gastrointestinal, 258 genitourinary, 199 lung, 218 head and neck, 11 brain, 137 hematologic, 58 multiple, 22 breast, 18 unknown, 13 sarcoma, 71 other and 12 gynecologic cancers. CCNT has had a significant impaired for patients enrolled in the program as evidence by reduced travel to the VA, improved access to care, decreased hospital stays and improving patient, family and provider satisfaction.
Implications: We present a unique interdisciplinary team approach to patient navigation that supports patient-centered care in addressing barriers to care for Veterans and assures timely access to cancer care.
Purpose: Create a custom patient navigation model and standard assessment tools that support an interdisciplinary team approach to address barriers to care for Veterans with cancer.
Background: Patient navigation is utilized throughout the country to address barriers to care in the most vulnerable of populations. A community needs assessment was conducted at the VA Puget Sound Health Care System in December 2014 to identify high-risk cohorts and facility barriers to care to drive the VA Puget Sound navigation team process. Veterans in identified cohorts thought to be at highest risk for barriers to care are enrolled in navigation services. Veterans are identified through formal consult, case finding and self-referral. The VA Puget Sound uses an interdisciplinary team approach that has been found to be successful in addressing complex barriers to cancer care. The VA Puget Sound Healthcare System Cancer Care Navigation Team (CCNT) consists of a Nurse Practitioner, Registered Nurse, Social Worker and a Medical Support Assistant who work together to fully address a wide range of physical, psychological and practical barriers to care that patients may experience throughout the cancer care continuum.
Methods: The CCNT uses standardized assessment tools, including a navigation intake form, the National Comprehensive Network (NCCN) Distress Thermometer and a functional assessment. The VA Puget Sound cancer navigation model is divided into four main processes based on the
cancer care continuum.
Results: Since initiation of the program in December of 2014, CCNT has enrolled over 1,295 patients diagnosed with cancer sites including: 291 gastrointestinal, 258 genitourinary, 199 lung, 218 head and neck, 11 brain, 137 hematologic, 58 multiple, 22 breast, 18 unknown, 13 sarcoma, 71 other and 12 gynecologic cancers. CCNT has had a significant impaired for patients enrolled in the program as evidence by reduced travel to the VA, improved access to care, decreased hospital stays and improving patient, family and provider satisfaction.
Implications: We present a unique interdisciplinary team approach to patient navigation that supports patient-centered care in addressing barriers to care for Veterans and assures timely access to cancer care.
Purpose: Create a custom patient navigation model and standard assessment tools that support an interdisciplinary team approach to address barriers to care for Veterans with cancer.
Background: Patient navigation is utilized throughout the country to address barriers to care in the most vulnerable of populations. A community needs assessment was conducted at the VA Puget Sound Health Care System in December 2014 to identify high-risk cohorts and facility barriers to care to drive the VA Puget Sound navigation team process. Veterans in identified cohorts thought to be at highest risk for barriers to care are enrolled in navigation services. Veterans are identified through formal consult, case finding and self-referral. The VA Puget Sound uses an interdisciplinary team approach that has been found to be successful in addressing complex barriers to cancer care. The VA Puget Sound Healthcare System Cancer Care Navigation Team (CCNT) consists of a Nurse Practitioner, Registered Nurse, Social Worker and a Medical Support Assistant who work together to fully address a wide range of physical, psychological and practical barriers to care that patients may experience throughout the cancer care continuum.
Methods: The CCNT uses standardized assessment tools, including a navigation intake form, the National Comprehensive Network (NCCN) Distress Thermometer and a functional assessment. The VA Puget Sound cancer navigation model is divided into four main processes based on the
cancer care continuum.
Results: Since initiation of the program in December of 2014, CCNT has enrolled over 1,295 patients diagnosed with cancer sites including: 291 gastrointestinal, 258 genitourinary, 199 lung, 218 head and neck, 11 brain, 137 hematologic, 58 multiple, 22 breast, 18 unknown, 13 sarcoma, 71 other and 12 gynecologic cancers. CCNT has had a significant impaired for patients enrolled in the program as evidence by reduced travel to the VA, improved access to care, decreased hospital stays and improving patient, family and provider satisfaction.
Implications: We present a unique interdisciplinary team approach to patient navigation that supports patient-centered care in addressing barriers to care for Veterans and assures timely access to cancer care.
Anti-CD20 Antibody Order Checks and Medication Use Evaluation Tracker Increase Hepatitis B Testing and Antiviral Treatment in VHA
Purpose: In patients initiating treatment with anti-CD20 antibodies (Ab), 20-60% with prior hepatitis B (HBV) infection not receiving HBV antiviral prophylaxis experience HBV reactivation—with hepatitis (33%), liver failure (13%), and death (5%). HBV reactivation is prevented with HBV antiviral therapy during and 12 months after anti-CD20 Ab therapy in patients with positive HBV surface antigen (HBsAg+) or HBV core antibody (HBcAb+). Our goal is to widely use anti-CD20 Ab order checks to increase testing and antiviral treatment to prevent HBV reactivation.
Background: Without HBV treatment in those at risk, fatal HBV reactivation affects 1 in 1,000 receiving rituximab. In a VHA analysis of 19,304 patients initiating anti-CD20 Ab (2002-14), > 60% of patients had HBV testing by 2014; 1 in 9 Veterans had either chronic (1-2% HBsAg+) or prior (9% HBcAb+) HBV, yet < 18% received HBV antiviral therapy. While information modestly affects behaviors, order checks with treatment algorithms can be > 95% effective.
Methods: Since 2015, our team has shared information widely, updated pharmacy criteria for use, and enabled HBV antiviral prescribing by all providers. To identify HBV testing or treatment omissions, we launched a Medication Use Evaluation Tracker (MUET), and programmed an anti- CD20 Ab order check that displays only if either HBV testing or treatment has not been done.
Results: Since 2014, HBV testing in patients initiating anti-CD20 Ab increased to 64-78% and HBV antiviral prophylaxis from < 18% to 44%. In November 2016, an anti-CD20 Ab order check was piloted at 3 sites and functional in CPRS with additional sites reporting favorable use. Additionally, a MUET was released for anti-CD20 Ab therapies providing an additional safety check.
Conclusions: VHA has increased HBV testing and antiviral treatment with anti-CD20 antibody initiation—yet more than half of patients remain at risk of HBV reactivation. Successfully used in up to 15 sites, programmed anti-CD20 Ab order checks highlight to providers when HBV testing
or antiviral prophylaxis is needed. Achieving broad use of this order check will increase HBV prophylaxis prescribing and decrease subsequent HBV reactivation. An anti-CD20 Ab MUET provides an additional safety check option for identifying at risk patient.
Purpose: In patients initiating treatment with anti-CD20 antibodies (Ab), 20-60% with prior hepatitis B (HBV) infection not receiving HBV antiviral prophylaxis experience HBV reactivation—with hepatitis (33%), liver failure (13%), and death (5%). HBV reactivation is prevented with HBV antiviral therapy during and 12 months after anti-CD20 Ab therapy in patients with positive HBV surface antigen (HBsAg+) or HBV core antibody (HBcAb+). Our goal is to widely use anti-CD20 Ab order checks to increase testing and antiviral treatment to prevent HBV reactivation.
Background: Without HBV treatment in those at risk, fatal HBV reactivation affects 1 in 1,000 receiving rituximab. In a VHA analysis of 19,304 patients initiating anti-CD20 Ab (2002-14), > 60% of patients had HBV testing by 2014; 1 in 9 Veterans had either chronic (1-2% HBsAg+) or prior (9% HBcAb+) HBV, yet < 18% received HBV antiviral therapy. While information modestly affects behaviors, order checks with treatment algorithms can be > 95% effective.
Methods: Since 2015, our team has shared information widely, updated pharmacy criteria for use, and enabled HBV antiviral prescribing by all providers. To identify HBV testing or treatment omissions, we launched a Medication Use Evaluation Tracker (MUET), and programmed an anti- CD20 Ab order check that displays only if either HBV testing or treatment has not been done.
Results: Since 2014, HBV testing in patients initiating anti-CD20 Ab increased to 64-78% and HBV antiviral prophylaxis from < 18% to 44%. In November 2016, an anti-CD20 Ab order check was piloted at 3 sites and functional in CPRS with additional sites reporting favorable use. Additionally, a MUET was released for anti-CD20 Ab therapies providing an additional safety check.
Conclusions: VHA has increased HBV testing and antiviral treatment with anti-CD20 antibody initiation—yet more than half of patients remain at risk of HBV reactivation. Successfully used in up to 15 sites, programmed anti-CD20 Ab order checks highlight to providers when HBV testing
or antiviral prophylaxis is needed. Achieving broad use of this order check will increase HBV prophylaxis prescribing and decrease subsequent HBV reactivation. An anti-CD20 Ab MUET provides an additional safety check option for identifying at risk patient.
Purpose: In patients initiating treatment with anti-CD20 antibodies (Ab), 20-60% with prior hepatitis B (HBV) infection not receiving HBV antiviral prophylaxis experience HBV reactivation—with hepatitis (33%), liver failure (13%), and death (5%). HBV reactivation is prevented with HBV antiviral therapy during and 12 months after anti-CD20 Ab therapy in patients with positive HBV surface antigen (HBsAg+) or HBV core antibody (HBcAb+). Our goal is to widely use anti-CD20 Ab order checks to increase testing and antiviral treatment to prevent HBV reactivation.
Background: Without HBV treatment in those at risk, fatal HBV reactivation affects 1 in 1,000 receiving rituximab. In a VHA analysis of 19,304 patients initiating anti-CD20 Ab (2002-14), > 60% of patients had HBV testing by 2014; 1 in 9 Veterans had either chronic (1-2% HBsAg+) or prior (9% HBcAb+) HBV, yet < 18% received HBV antiviral therapy. While information modestly affects behaviors, order checks with treatment algorithms can be > 95% effective.
Methods: Since 2015, our team has shared information widely, updated pharmacy criteria for use, and enabled HBV antiviral prescribing by all providers. To identify HBV testing or treatment omissions, we launched a Medication Use Evaluation Tracker (MUET), and programmed an anti- CD20 Ab order check that displays only if either HBV testing or treatment has not been done.
Results: Since 2014, HBV testing in patients initiating anti-CD20 Ab increased to 64-78% and HBV antiviral prophylaxis from < 18% to 44%. In November 2016, an anti-CD20 Ab order check was piloted at 3 sites and functional in CPRS with additional sites reporting favorable use. Additionally, a MUET was released for anti-CD20 Ab therapies providing an additional safety check.
Conclusions: VHA has increased HBV testing and antiviral treatment with anti-CD20 antibody initiation—yet more than half of patients remain at risk of HBV reactivation. Successfully used in up to 15 sites, programmed anti-CD20 Ab order checks highlight to providers when HBV testing
or antiviral prophylaxis is needed. Achieving broad use of this order check will increase HBV prophylaxis prescribing and decrease subsequent HBV reactivation. An anti-CD20 Ab MUET provides an additional safety check option for identifying at risk patient.
Veteran Satisfaction With Video- Based Telemedicine for Pre-Transplant Valuation
Purpose: The primary purpose of this quality improvement project was to measure and subsequently improve patient satisfaction with video-based telemedicine (VBT).
Background: Since April 1, 2015, the majority of stem cell transplant patients referred to the Tennessee Valley Healthcare System from throughout the United States were evaluated using VBT. Reduction in time to evaluation and overall cost savings have been well documented. However, we have never evaluated patient satisfaction with the VBT process.
Methods: We conducted a retrospective record review and determined that (n = 31) patients were evaluated during FY 2016. We found that (n = 16) patients were deceased, and (n = 4) patients were critically ill and unable to complete the survey. We developed and mailed a 12 question anonymous survey, to the remaining (n = 111). Veterans evaluated using VBT during the selected time frame. Questions were framed with a standard Likert scale from 1-4, with 4 being excellent and 1 being poor. We considered a score greater than 3.5 to translate to a high level of satisfaction. A ranking of less than 2.5
was equated with low satisfaction. Surveys were mailed to the patient’s address as listed in CPRS on March 6, 2017 and collected through April 10, 2017. We collected demographic and disease data on all patients surveyed.
Data Analysis: There was a 62.1% response rate (n = 69) in terms of surveys returned within the specified time frame. We tabulated average patient satisfaction data based on numeric responses to each question. We calculated demographic data including age, sex, disease, mileage from the patient’s VA to transplant center.
Results: Overall rating of care during the VBT evaluation was very good at 92.5% (3.7) with no category rated less than 3.4 (85%). Average age of the patient in the sample was 61.45 years, predominately male (n = 106), most prevalent disease was multiple myeloma (n = 53) average distance from transplant center; 559 miles. Total round-trip mileage saved by VBT 124,278 miles.
Conclusions: Patients have a high degree of satisfaction with VBT in the pre transplant evaluation setting.
Purpose: The primary purpose of this quality improvement project was to measure and subsequently improve patient satisfaction with video-based telemedicine (VBT).
Background: Since April 1, 2015, the majority of stem cell transplant patients referred to the Tennessee Valley Healthcare System from throughout the United States were evaluated using VBT. Reduction in time to evaluation and overall cost savings have been well documented. However, we have never evaluated patient satisfaction with the VBT process.
Methods: We conducted a retrospective record review and determined that (n = 31) patients were evaluated during FY 2016. We found that (n = 16) patients were deceased, and (n = 4) patients were critically ill and unable to complete the survey. We developed and mailed a 12 question anonymous survey, to the remaining (n = 111). Veterans evaluated using VBT during the selected time frame. Questions were framed with a standard Likert scale from 1-4, with 4 being excellent and 1 being poor. We considered a score greater than 3.5 to translate to a high level of satisfaction. A ranking of less than 2.5
was equated with low satisfaction. Surveys were mailed to the patient’s address as listed in CPRS on March 6, 2017 and collected through April 10, 2017. We collected demographic and disease data on all patients surveyed.
Data Analysis: There was a 62.1% response rate (n = 69) in terms of surveys returned within the specified time frame. We tabulated average patient satisfaction data based on numeric responses to each question. We calculated demographic data including age, sex, disease, mileage from the patient’s VA to transplant center.
Results: Overall rating of care during the VBT evaluation was very good at 92.5% (3.7) with no category rated less than 3.4 (85%). Average age of the patient in the sample was 61.45 years, predominately male (n = 106), most prevalent disease was multiple myeloma (n = 53) average distance from transplant center; 559 miles. Total round-trip mileage saved by VBT 124,278 miles.
Conclusions: Patients have a high degree of satisfaction with VBT in the pre transplant evaluation setting.
Purpose: The primary purpose of this quality improvement project was to measure and subsequently improve patient satisfaction with video-based telemedicine (VBT).
Background: Since April 1, 2015, the majority of stem cell transplant patients referred to the Tennessee Valley Healthcare System from throughout the United States were evaluated using VBT. Reduction in time to evaluation and overall cost savings have been well documented. However, we have never evaluated patient satisfaction with the VBT process.
Methods: We conducted a retrospective record review and determined that (n = 31) patients were evaluated during FY 2016. We found that (n = 16) patients were deceased, and (n = 4) patients were critically ill and unable to complete the survey. We developed and mailed a 12 question anonymous survey, to the remaining (n = 111). Veterans evaluated using VBT during the selected time frame. Questions were framed with a standard Likert scale from 1-4, with 4 being excellent and 1 being poor. We considered a score greater than 3.5 to translate to a high level of satisfaction. A ranking of less than 2.5
was equated with low satisfaction. Surveys were mailed to the patient’s address as listed in CPRS on March 6, 2017 and collected through April 10, 2017. We collected demographic and disease data on all patients surveyed.
Data Analysis: There was a 62.1% response rate (n = 69) in terms of surveys returned within the specified time frame. We tabulated average patient satisfaction data based on numeric responses to each question. We calculated demographic data including age, sex, disease, mileage from the patient’s VA to transplant center.
Results: Overall rating of care during the VBT evaluation was very good at 92.5% (3.7) with no category rated less than 3.4 (85%). Average age of the patient in the sample was 61.45 years, predominately male (n = 106), most prevalent disease was multiple myeloma (n = 53) average distance from transplant center; 559 miles. Total round-trip mileage saved by VBT 124,278 miles.
Conclusions: Patients have a high degree of satisfaction with VBT in the pre transplant evaluation setting.
Cancer Fast Track e-Consults: An Innovative Approach to e-Consultation
Purpose: To improve access to specialty care for Veterans with a cancer concern and to improve communication among providers.
Background: Providers at the Cleveland VA Medical Center (CVAMC) voiced concerns that the process for Veterans with a cancer concern was fragmented, leading to potential delays in cancer diagnosis. The CVAMC developed an innovative process for the Cancer Fast Track Econsult (CFTE-C) to assist providers with expediting care for Veterans with a cancer concern. This process aims to improve communication between primary and specialty care providers, expedite pre-cancer workups, and allow more meaningful face to face first oncology specialty visits.
Methods: The E-consult is initiated by a primary care provider (PCP) in CPRS. After entering the CFTE-C an oncologist triages the consult to determine workup needed. The care coordinator (CC) ensures implementation of the plan of care and tracks its progression. This is done by the CC entering each Veteran into the Task Tracker (TT), a smart calendar that is used for communication and seamless coordination for selected Veterans. The CC continuously monitors the progression of diagnostic testing to ensure timeliness and identify delays. During the diagnostic process, the CC communicates the process to the PCP in CPRS. After cancer is confirmed or ruled out the CC discusses treatment plan with oncologist, documents in CPRS and notifies PCP.
Results: Since July 2015 there have been a total 145 veterans that have been referred to the CFTE-C. The average time from consultation to first action is 3 days. There is an average of about 6 CFTE-C consults monthly.
Implications: The CFTE-C process of using the TT allows the CC to monitor the Veterans workup and identify delays and barriers to care. The CC assists in eliminating any barriers or delays identified. The CFTE-C is underutilized by PCP’s and efforts are underway to improving utilization
by identifying a PCP champion in the outpatient clinics. There is also a need for clear measures of timeliness of care. Templated notes are in production to allow for clear tracking of the entire process including a clear handoff to PCP or referring provider.
Purpose: To improve access to specialty care for Veterans with a cancer concern and to improve communication among providers.
Background: Providers at the Cleveland VA Medical Center (CVAMC) voiced concerns that the process for Veterans with a cancer concern was fragmented, leading to potential delays in cancer diagnosis. The CVAMC developed an innovative process for the Cancer Fast Track Econsult (CFTE-C) to assist providers with expediting care for Veterans with a cancer concern. This process aims to improve communication between primary and specialty care providers, expedite pre-cancer workups, and allow more meaningful face to face first oncology specialty visits.
Methods: The E-consult is initiated by a primary care provider (PCP) in CPRS. After entering the CFTE-C an oncologist triages the consult to determine workup needed. The care coordinator (CC) ensures implementation of the plan of care and tracks its progression. This is done by the CC entering each Veteran into the Task Tracker (TT), a smart calendar that is used for communication and seamless coordination for selected Veterans. The CC continuously monitors the progression of diagnostic testing to ensure timeliness and identify delays. During the diagnostic process, the CC communicates the process to the PCP in CPRS. After cancer is confirmed or ruled out the CC discusses treatment plan with oncologist, documents in CPRS and notifies PCP.
Results: Since July 2015 there have been a total 145 veterans that have been referred to the CFTE-C. The average time from consultation to first action is 3 days. There is an average of about 6 CFTE-C consults monthly.
Implications: The CFTE-C process of using the TT allows the CC to monitor the Veterans workup and identify delays and barriers to care. The CC assists in eliminating any barriers or delays identified. The CFTE-C is underutilized by PCP’s and efforts are underway to improving utilization
by identifying a PCP champion in the outpatient clinics. There is also a need for clear measures of timeliness of care. Templated notes are in production to allow for clear tracking of the entire process including a clear handoff to PCP or referring provider.
Purpose: To improve access to specialty care for Veterans with a cancer concern and to improve communication among providers.
Background: Providers at the Cleveland VA Medical Center (CVAMC) voiced concerns that the process for Veterans with a cancer concern was fragmented, leading to potential delays in cancer diagnosis. The CVAMC developed an innovative process for the Cancer Fast Track Econsult (CFTE-C) to assist providers with expediting care for Veterans with a cancer concern. This process aims to improve communication between primary and specialty care providers, expedite pre-cancer workups, and allow more meaningful face to face first oncology specialty visits.
Methods: The E-consult is initiated by a primary care provider (PCP) in CPRS. After entering the CFTE-C an oncologist triages the consult to determine workup needed. The care coordinator (CC) ensures implementation of the plan of care and tracks its progression. This is done by the CC entering each Veteran into the Task Tracker (TT), a smart calendar that is used for communication and seamless coordination for selected Veterans. The CC continuously monitors the progression of diagnostic testing to ensure timeliness and identify delays. During the diagnostic process, the CC communicates the process to the PCP in CPRS. After cancer is confirmed or ruled out the CC discusses treatment plan with oncologist, documents in CPRS and notifies PCP.
Results: Since July 2015 there have been a total 145 veterans that have been referred to the CFTE-C. The average time from consultation to first action is 3 days. There is an average of about 6 CFTE-C consults monthly.
Implications: The CFTE-C process of using the TT allows the CC to monitor the Veterans workup and identify delays and barriers to care. The CC assists in eliminating any barriers or delays identified. The CFTE-C is underutilized by PCP’s and efforts are underway to improving utilization
by identifying a PCP champion in the outpatient clinics. There is also a need for clear measures of timeliness of care. Templated notes are in production to allow for clear tracking of the entire process including a clear handoff to PCP or referring provider.
How Can VA Optimize Palliative Oncology Care? Updates on AVAHO Palliative Care Research Committee Projects
Purpose: Palliative care is essential to oncology. This abstract describes the AVAHO Palliative Care Research Committee, its objectives, and ongoing projects that highlight the committee’s productive multidisciplinary and interinstitutional collaboration.
Background: The American Society of Clinical Oncology recommends palliative care for patients with metastatic lung cancer and other symptomatic advanced malignancies. VA mandates inpatient palliative care services for all medical facilities. However, it is not clearly known how palliative care is integrated into standard VA outpatient oncology practice. In addition, questions remain regarding the optimal way(s) to provide palliative oncology care. Established in 2015, the AVAHO Palliative Care Research Committee currently has over a dozen members from different VA institutions. The Committee’s mission is to develop partnerships among clinicians, pharmacists, social workers, researchers, and VA leadership with the shared goal of providing optimal palliative oncology care within the VA.
Methods: Last year, we identified 2 initial approaches to address these questions, and this year we will report on our progress. First, we submitted a proposal to the VA Evidence-Based Synthesis Program (ESP) to review the evidence regarding optimal palliative care delivery methods and the feasibility of providing on-site palliative care embedded into VA oncology clinics. The ESP accepted our proposal and plans to complete their review July 2017. Second, we proposed a project to assess on-site palliative care availability in VA oncology clinics. With the support of the 2017 AVAHO Research Scholarship, we are moving forward with this project to work with VA oncology providers to understand their referral patterns, available palliative care resources, and barriers to providing optimal palliative care.
Results: At the AVAHO 2017 meeting, we will review the VA ESP results on optimal palliative oncology care delivery. In addition, we will share the progress on our ongoing project to better understand VA oncologist’s referral patterns, resources, and barriers to providing optimal palliative oncology care.
Conclusions: The AVAHO Palliative Care Research Committee represents a multidisciplinary and inter-institutional collaboration with a common goal of optimizing VA palliative oncology care. This committee is a model of how AVAHO can foster productive collaborations.
Purpose: Palliative care is essential to oncology. This abstract describes the AVAHO Palliative Care Research Committee, its objectives, and ongoing projects that highlight the committee’s productive multidisciplinary and interinstitutional collaboration.
Background: The American Society of Clinical Oncology recommends palliative care for patients with metastatic lung cancer and other symptomatic advanced malignancies. VA mandates inpatient palliative care services for all medical facilities. However, it is not clearly known how palliative care is integrated into standard VA outpatient oncology practice. In addition, questions remain regarding the optimal way(s) to provide palliative oncology care. Established in 2015, the AVAHO Palliative Care Research Committee currently has over a dozen members from different VA institutions. The Committee’s mission is to develop partnerships among clinicians, pharmacists, social workers, researchers, and VA leadership with the shared goal of providing optimal palliative oncology care within the VA.
Methods: Last year, we identified 2 initial approaches to address these questions, and this year we will report on our progress. First, we submitted a proposal to the VA Evidence-Based Synthesis Program (ESP) to review the evidence regarding optimal palliative care delivery methods and the feasibility of providing on-site palliative care embedded into VA oncology clinics. The ESP accepted our proposal and plans to complete their review July 2017. Second, we proposed a project to assess on-site palliative care availability in VA oncology clinics. With the support of the 2017 AVAHO Research Scholarship, we are moving forward with this project to work with VA oncology providers to understand their referral patterns, available palliative care resources, and barriers to providing optimal palliative care.
Results: At the AVAHO 2017 meeting, we will review the VA ESP results on optimal palliative oncology care delivery. In addition, we will share the progress on our ongoing project to better understand VA oncologist’s referral patterns, resources, and barriers to providing optimal palliative oncology care.
Conclusions: The AVAHO Palliative Care Research Committee represents a multidisciplinary and inter-institutional collaboration with a common goal of optimizing VA palliative oncology care. This committee is a model of how AVAHO can foster productive collaborations.
Purpose: Palliative care is essential to oncology. This abstract describes the AVAHO Palliative Care Research Committee, its objectives, and ongoing projects that highlight the committee’s productive multidisciplinary and interinstitutional collaboration.
Background: The American Society of Clinical Oncology recommends palliative care for patients with metastatic lung cancer and other symptomatic advanced malignancies. VA mandates inpatient palliative care services for all medical facilities. However, it is not clearly known how palliative care is integrated into standard VA outpatient oncology practice. In addition, questions remain regarding the optimal way(s) to provide palliative oncology care. Established in 2015, the AVAHO Palliative Care Research Committee currently has over a dozen members from different VA institutions. The Committee’s mission is to develop partnerships among clinicians, pharmacists, social workers, researchers, and VA leadership with the shared goal of providing optimal palliative oncology care within the VA.
Methods: Last year, we identified 2 initial approaches to address these questions, and this year we will report on our progress. First, we submitted a proposal to the VA Evidence-Based Synthesis Program (ESP) to review the evidence regarding optimal palliative care delivery methods and the feasibility of providing on-site palliative care embedded into VA oncology clinics. The ESP accepted our proposal and plans to complete their review July 2017. Second, we proposed a project to assess on-site palliative care availability in VA oncology clinics. With the support of the 2017 AVAHO Research Scholarship, we are moving forward with this project to work with VA oncology providers to understand their referral patterns, available palliative care resources, and barriers to providing optimal palliative care.
Results: At the AVAHO 2017 meeting, we will review the VA ESP results on optimal palliative oncology care delivery. In addition, we will share the progress on our ongoing project to better understand VA oncologist’s referral patterns, resources, and barriers to providing optimal palliative oncology care.
Conclusions: The AVAHO Palliative Care Research Committee represents a multidisciplinary and inter-institutional collaboration with a common goal of optimizing VA palliative oncology care. This committee is a model of how AVAHO can foster productive collaborations.
Evaluating Psychsocial Distress in Veterans and Their Caregivers at the Palo Alto VA
Purpose: This project was created to expand the psychosocial distress screening program at VA Palo Alto Health Care System (VAPAHCS) to explore the levels of distress experienced by Veterans’ caregivers. Caregiver distress and burden can have a far-reaching impact on patient care, health care costs, and clinical outcomes. VAPAHCS has had a procedure in place to measure Veteran cancer patient distress levels since 2013. Clinical experiences administering distress screens in our outpatient oncology clinics suggested that caregivers accompanying Veterans to appointments may be experiencing elevated levels of distress. Thus, a program evaluation project was conducted in order to measure caregiver distress and compare distress between Veterans and caregivers.
Methods: Veterans recently diagnosed with cancer were screened for distress by a psychologist, social worker, or psychology trainee during regularly scheduled oncology appointments using the National Comprehensive Cancer Network Distress Thermometer and Symptom Checklist. Beginning in January 2016, the Distress Thermometer question was also administered verbally to any caregivers present during the Veteran’s screen.
Data Analysis: Descriptive statistics were used to explore the level of distress by Veterans and caregivers. An independent samples t test was conducted to compare overall level of distress between the two groups.
Results: A total of 483 Veterans and 93 caregivers completed distress screening during the program evaluation period (January 2016-June 2017). Average level of distress for caregivers was 3.45 (0 = no distress, 10 = extreme distress). Average level of distress for caregivers was 5.09 (0 = no distress, 10 = extreme distress). T test was found to be clinically significant, t (574)= 5.19, P < .0001. 63% of caregivers were a spouse, partner, or significant other, 22% children, and 15% ‘other’.
Implications: These results indicate that caregivers endorse, on average, distress levels above the suggested cutoff for clinically significant distress (> 4), whereas Veterans are endorsing, on average, distress below the cutoff. This suggests that additional resources for caregiver distress are warranted in our clinics. Future directions include the development of additional caregiver support programs within the VAPAHCS and improved facilitation of referrals to caregiver support outside of the VAPAHCS system.
Purpose: This project was created to expand the psychosocial distress screening program at VA Palo Alto Health Care System (VAPAHCS) to explore the levels of distress experienced by Veterans’ caregivers. Caregiver distress and burden can have a far-reaching impact on patient care, health care costs, and clinical outcomes. VAPAHCS has had a procedure in place to measure Veteran cancer patient distress levels since 2013. Clinical experiences administering distress screens in our outpatient oncology clinics suggested that caregivers accompanying Veterans to appointments may be experiencing elevated levels of distress. Thus, a program evaluation project was conducted in order to measure caregiver distress and compare distress between Veterans and caregivers.
Methods: Veterans recently diagnosed with cancer were screened for distress by a psychologist, social worker, or psychology trainee during regularly scheduled oncology appointments using the National Comprehensive Cancer Network Distress Thermometer and Symptom Checklist. Beginning in January 2016, the Distress Thermometer question was also administered verbally to any caregivers present during the Veteran’s screen.
Data Analysis: Descriptive statistics were used to explore the level of distress by Veterans and caregivers. An independent samples t test was conducted to compare overall level of distress between the two groups.
Results: A total of 483 Veterans and 93 caregivers completed distress screening during the program evaluation period (January 2016-June 2017). Average level of distress for caregivers was 3.45 (0 = no distress, 10 = extreme distress). Average level of distress for caregivers was 5.09 (0 = no distress, 10 = extreme distress). T test was found to be clinically significant, t (574)= 5.19, P < .0001. 63% of caregivers were a spouse, partner, or significant other, 22% children, and 15% ‘other’.
Implications: These results indicate that caregivers endorse, on average, distress levels above the suggested cutoff for clinically significant distress (> 4), whereas Veterans are endorsing, on average, distress below the cutoff. This suggests that additional resources for caregiver distress are warranted in our clinics. Future directions include the development of additional caregiver support programs within the VAPAHCS and improved facilitation of referrals to caregiver support outside of the VAPAHCS system.
Purpose: This project was created to expand the psychosocial distress screening program at VA Palo Alto Health Care System (VAPAHCS) to explore the levels of distress experienced by Veterans’ caregivers. Caregiver distress and burden can have a far-reaching impact on patient care, health care costs, and clinical outcomes. VAPAHCS has had a procedure in place to measure Veteran cancer patient distress levels since 2013. Clinical experiences administering distress screens in our outpatient oncology clinics suggested that caregivers accompanying Veterans to appointments may be experiencing elevated levels of distress. Thus, a program evaluation project was conducted in order to measure caregiver distress and compare distress between Veterans and caregivers.
Methods: Veterans recently diagnosed with cancer were screened for distress by a psychologist, social worker, or psychology trainee during regularly scheduled oncology appointments using the National Comprehensive Cancer Network Distress Thermometer and Symptom Checklist. Beginning in January 2016, the Distress Thermometer question was also administered verbally to any caregivers present during the Veteran’s screen.
Data Analysis: Descriptive statistics were used to explore the level of distress by Veterans and caregivers. An independent samples t test was conducted to compare overall level of distress between the two groups.
Results: A total of 483 Veterans and 93 caregivers completed distress screening during the program evaluation period (January 2016-June 2017). Average level of distress for caregivers was 3.45 (0 = no distress, 10 = extreme distress). Average level of distress for caregivers was 5.09 (0 = no distress, 10 = extreme distress). T test was found to be clinically significant, t (574)= 5.19, P < .0001. 63% of caregivers were a spouse, partner, or significant other, 22% children, and 15% ‘other’.
Implications: These results indicate that caregivers endorse, on average, distress levels above the suggested cutoff for clinically significant distress (> 4), whereas Veterans are endorsing, on average, distress below the cutoff. This suggests that additional resources for caregiver distress are warranted in our clinics. Future directions include the development of additional caregiver support programs within the VAPAHCS and improved facilitation of referrals to caregiver support outside of the VAPAHCS system.
Electronic Consultation: An Efficient and Effective Way to Manage Hematology Consults
Purpose: To demonstrate our facility’s process of successful integration of hematology electronic consultations to provide patient-centered, efficient and effective outpatient specialty care.
Background: The hematology/oncology section lost a nurse practitioner in 2013. As a way to provide continued high quality and timely care to hematology patients, electronic consultation was broadly implemented within the section.
Methods: A comprehensive electronic consultation program was established as per the Specialty Care Transformation Initiative guidelines. All Hematology consults (face to face or electronic) are addressed by the section chief.
Results: Since 2012, the section has answered over 3,600 consults electronically. In 2016 there were a total of 1,160 electronic consults placed to the service. Each year since 2012 the percentage of outpatient hematology volume that is addressed by electronic consultations has increased. During 2016, 78% of outpatient hematology volume was addressed electronically. Additionally, 85% of those patients treated with electronic consultations did not require a face to face visit within the subsequent 12 months of initial electronic consultation. Based on zip code analysis of those Veterans who had electronic consultations in 2016, we estimated that there were over 1,200 hours of driving time and nearly 70,000 miles of driving distance saved.
Conclusions: Many VAMCs are using electronic consultation to provide efficient and patient-centered specialty care. Our center has quantified the impact of successful implementation and looks to share our experience with others. Additionally, during poster presentation we will provide a toolkit for implementation, to include templated consult notes for specific hematologic conditions.
Purpose: To demonstrate our facility’s process of successful integration of hematology electronic consultations to provide patient-centered, efficient and effective outpatient specialty care.
Background: The hematology/oncology section lost a nurse practitioner in 2013. As a way to provide continued high quality and timely care to hematology patients, electronic consultation was broadly implemented within the section.
Methods: A comprehensive electronic consultation program was established as per the Specialty Care Transformation Initiative guidelines. All Hematology consults (face to face or electronic) are addressed by the section chief.
Results: Since 2012, the section has answered over 3,600 consults electronically. In 2016 there were a total of 1,160 electronic consults placed to the service. Each year since 2012 the percentage of outpatient hematology volume that is addressed by electronic consultations has increased. During 2016, 78% of outpatient hematology volume was addressed electronically. Additionally, 85% of those patients treated with electronic consultations did not require a face to face visit within the subsequent 12 months of initial electronic consultation. Based on zip code analysis of those Veterans who had electronic consultations in 2016, we estimated that there were over 1,200 hours of driving time and nearly 70,000 miles of driving distance saved.
Conclusions: Many VAMCs are using electronic consultation to provide efficient and patient-centered specialty care. Our center has quantified the impact of successful implementation and looks to share our experience with others. Additionally, during poster presentation we will provide a toolkit for implementation, to include templated consult notes for specific hematologic conditions.
Purpose: To demonstrate our facility’s process of successful integration of hematology electronic consultations to provide patient-centered, efficient and effective outpatient specialty care.
Background: The hematology/oncology section lost a nurse practitioner in 2013. As a way to provide continued high quality and timely care to hematology patients, electronic consultation was broadly implemented within the section.
Methods: A comprehensive electronic consultation program was established as per the Specialty Care Transformation Initiative guidelines. All Hematology consults (face to face or electronic) are addressed by the section chief.
Results: Since 2012, the section has answered over 3,600 consults electronically. In 2016 there were a total of 1,160 electronic consults placed to the service. Each year since 2012 the percentage of outpatient hematology volume that is addressed by electronic consultations has increased. During 2016, 78% of outpatient hematology volume was addressed electronically. Additionally, 85% of those patients treated with electronic consultations did not require a face to face visit within the subsequent 12 months of initial electronic consultation. Based on zip code analysis of those Veterans who had electronic consultations in 2016, we estimated that there were over 1,200 hours of driving time and nearly 70,000 miles of driving distance saved.
Conclusions: Many VAMCs are using electronic consultation to provide efficient and patient-centered specialty care. Our center has quantified the impact of successful implementation and looks to share our experience with others. Additionally, during poster presentation we will provide a toolkit for implementation, to include templated consult notes for specific hematologic conditions.
Getting it right at the end of life
Although the concept of the living will was first proposed in 1969
In contrast, an informal search of PubMed reveals that at least 38 articles on advance directives and end-of-life care have been published during the first 7 months of 2017. And a feature article in this month’s issue of JFP makes one more. Why is there such strong interest now in an issue that seldom arose when I began practice in 1978?
More complex, less personalized medicine. As medical care has become more sophisticated, there is a great deal more we can do to keep people alive as they approach the end of life, and a great many more decisions to be made.
Additionally, people are much less likely today to be cared for in their dying days by a family physician who knows them, their wishes, and their family well. In my early years in small-town practice, I was present when my patients were dying, and I usually knew their family members. Family meetings were easy to arrange, and we quickly came to a consensus about what to do and what not to do. If I was not available, one of my practice partners was. We cared for our patients in the office, nursing home, and hospital. Now, most dying hospitalized patients are cared for by hospitalists who may be meeting the patient for the first time.
Getting more people to participate. Consequently, it is important to understand patients’ wishes for end-of-life care and to document those wishes in writing, using things like a POLST (Physician Orders for Life-Sustaining Treatment) form. Although randomized trials support the value of advance care planning, especially in primary care settings,3,4 two-thirds of Americans have not completed an advance directive.5 Rolnick suggests we “delegalize” the process to remove barriers and make it easier for people to execute such documents and integrate them into health care systems.6
Make it part of your office routine. A 70-year-old patient of mine with advanced COPD arrived at his office visit last month with advance directive and POLST forms in hand. We had an excellent, frank conversation, spiced with humor that he supplied, about his wishes for end-of-life care. Just like so many other tasks that we must squeeze into our busy schedules, this is one that we should hard-wire into our office systems and routines.
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. Schneiderman LJ, Arras JD. Counseling patients to counsel physicians on future care in the event of patient incompetence. Ann Intern Med. 1985;102:693-698.
3. Weathers E, O’Caoimh R, Cornally N, et al. Advance care planning: a systematic review of randomised controlled trials conducted with older adults. Maturitas. 2016;91:101-109.
4. Tierney WM, Dexter PR, Gramelspacher GP, et al. The effect of discussions about advance directives on patients’ satisfaction with primary care. J Gen Intern Med. 2001;16:32-40.
5. Yadav KN, Gabler NB, Cooney E, et al. Approximately one in three US adults completes any type of advance directive for end-of-life care. Health Aff (Millwood). 2017;36:1244-1251.
6. Rolnick JA, Asch DA, Halpern SD. Delegalizing advance directives—facilitating advance care planning. N Engl J Med. 2017;376:2105-2107.
Although the concept of the living will was first proposed in 1969
In contrast, an informal search of PubMed reveals that at least 38 articles on advance directives and end-of-life care have been published during the first 7 months of 2017. And a feature article in this month’s issue of JFP makes one more. Why is there such strong interest now in an issue that seldom arose when I began practice in 1978?
More complex, less personalized medicine. As medical care has become more sophisticated, there is a great deal more we can do to keep people alive as they approach the end of life, and a great many more decisions to be made.
Additionally, people are much less likely today to be cared for in their dying days by a family physician who knows them, their wishes, and their family well. In my early years in small-town practice, I was present when my patients were dying, and I usually knew their family members. Family meetings were easy to arrange, and we quickly came to a consensus about what to do and what not to do. If I was not available, one of my practice partners was. We cared for our patients in the office, nursing home, and hospital. Now, most dying hospitalized patients are cared for by hospitalists who may be meeting the patient for the first time.
Getting more people to participate. Consequently, it is important to understand patients’ wishes for end-of-life care and to document those wishes in writing, using things like a POLST (Physician Orders for Life-Sustaining Treatment) form. Although randomized trials support the value of advance care planning, especially in primary care settings,3,4 two-thirds of Americans have not completed an advance directive.5 Rolnick suggests we “delegalize” the process to remove barriers and make it easier for people to execute such documents and integrate them into health care systems.6
Make it part of your office routine. A 70-year-old patient of mine with advanced COPD arrived at his office visit last month with advance directive and POLST forms in hand. We had an excellent, frank conversation, spiced with humor that he supplied, about his wishes for end-of-life care. Just like so many other tasks that we must squeeze into our busy schedules, this is one that we should hard-wire into our office systems and routines.
Although the concept of the living will was first proposed in 1969
In contrast, an informal search of PubMed reveals that at least 38 articles on advance directives and end-of-life care have been published during the first 7 months of 2017. And a feature article in this month’s issue of JFP makes one more. Why is there such strong interest now in an issue that seldom arose when I began practice in 1978?
More complex, less personalized medicine. As medical care has become more sophisticated, there is a great deal more we can do to keep people alive as they approach the end of life, and a great many more decisions to be made.
Additionally, people are much less likely today to be cared for in their dying days by a family physician who knows them, their wishes, and their family well. In my early years in small-town practice, I was present when my patients were dying, and I usually knew their family members. Family meetings were easy to arrange, and we quickly came to a consensus about what to do and what not to do. If I was not available, one of my practice partners was. We cared for our patients in the office, nursing home, and hospital. Now, most dying hospitalized patients are cared for by hospitalists who may be meeting the patient for the first time.
Getting more people to participate. Consequently, it is important to understand patients’ wishes for end-of-life care and to document those wishes in writing, using things like a POLST (Physician Orders for Life-Sustaining Treatment) form. Although randomized trials support the value of advance care planning, especially in primary care settings,3,4 two-thirds of Americans have not completed an advance directive.5 Rolnick suggests we “delegalize” the process to remove barriers and make it easier for people to execute such documents and integrate them into health care systems.6
Make it part of your office routine. A 70-year-old patient of mine with advanced COPD arrived at his office visit last month with advance directive and POLST forms in hand. We had an excellent, frank conversation, spiced with humor that he supplied, about his wishes for end-of-life care. Just like so many other tasks that we must squeeze into our busy schedules, this is one that we should hard-wire into our office systems and routines.
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. Schneiderman LJ, Arras JD. Counseling patients to counsel physicians on future care in the event of patient incompetence. Ann Intern Med. 1985;102:693-698.
3. Weathers E, O’Caoimh R, Cornally N, et al. Advance care planning: a systematic review of randomised controlled trials conducted with older adults. Maturitas. 2016;91:101-109.
4. Tierney WM, Dexter PR, Gramelspacher GP, et al. The effect of discussions about advance directives on patients’ satisfaction with primary care. J Gen Intern Med. 2001;16:32-40.
5. Yadav KN, Gabler NB, Cooney E, et al. Approximately one in three US adults completes any type of advance directive for end-of-life care. Health Aff (Millwood). 2017;36:1244-1251.
6. Rolnick JA, Asch DA, Halpern SD. Delegalizing advance directives—facilitating advance care planning. N Engl J Med. 2017;376:2105-2107.
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. Schneiderman LJ, Arras JD. Counseling patients to counsel physicians on future care in the event of patient incompetence. Ann Intern Med. 1985;102:693-698.
3. Weathers E, O’Caoimh R, Cornally N, et al. Advance care planning: a systematic review of randomised controlled trials conducted with older adults. Maturitas. 2016;91:101-109.
4. Tierney WM, Dexter PR, Gramelspacher GP, et al. The effect of discussions about advance directives on patients’ satisfaction with primary care. J Gen Intern Med. 2001;16:32-40.
5. Yadav KN, Gabler NB, Cooney E, et al. Approximately one in three US adults completes any type of advance directive for end-of-life care. Health Aff (Millwood). 2017;36:1244-1251.
6. Rolnick JA, Asch DA, Halpern SD. Delegalizing advance directives—facilitating advance care planning. N Engl J Med. 2017;376:2105-2107.
Advance care planning: Making it easier for patients (and you)
With the number of aging Americans projected to grow dramatically in the next several years, the need for primary palliative care and advance care planning (ACP) is more important than ever. Patients and their families want and expect palliative care when needed, but initial conversations about ACP can be difficult for them. Appropriate timing in raising this subject and clear communication can give patients the opportunity, while they are still independent, to set their goals for medical care.
For the past several decades, political decisions and judicial cases have shaped palliative care as we know it today. And its shape is still evolving. In support of ACP, advocacy groups at a national level are developing models that practitioners can use to engage patients in setting goals. And Medicare is now reimbursing primary care providers for this work that they have been doing for years (although many still may not be billing for the service).
Finally, the busy primary care office may have its own set of challenges in addressing ACP. Our aim in this review is to identify the barriers we face and the solutions we can implement to make a difference in our patients’ end-of-life care planning.
[polldaddy:9795119]
Landmark events have defined advance care planning today
In 1969, Luis Kutner, an Illinois attorney, proposed the idea of a “living will,” envisioned as a document specifying the types of treatment a person would be willing to receive were they unable at a later time to participate in making a decision.1 In 1976, California became the first state to give living wills the power of the law through the Natural Death Act.2
Throughout the 1970s and '80s, several high-profile court cases brought this idea into the national spotlight. In 1975, the New Jersey Supreme Court granted the parents of 21-year-old Karen Ann Quinlan the right to discontinue the treatment sustaining her in a persistent vegetative state. Ms. Quinlan was removed from the ventilator and lived 9 more months before dying in a nursing home.
A few years later, Nancy Cruzan, a 32-year-old woman involved in a 1983 motor vehicle accident, was also in a persistent vegetative state and remained so until 1988 when her parents asked that her feeding tube be removed. The hospital refused, indicating that it would lead to her death. The family sued and the case eventually went to the US Supreme Court in 1989.
In a 5-to-4 decision, the Supreme Court ruled that a state was legally able to require “clear and convincing evidence” of a patient’s wish for removal of life-sustaining therapies. Cruzan’s family was able to provide such evidence and her artificial nutrition was withheld. She died 12 days later.
The Cruzan case was instrumental in furthering ACP, leading to the passage of the Patient Self Determination Act (PSDA) by Congress in 1990. All federally funded health care facilities were now required to educate patients of their rights in determining their medical care and to ask about advance directives.3 The ACP movement gained additional momentum from the landmark SUPPORT study that documented shortcomings in communication between physicians and patients/families about treatment preferences and end-of-life care in US hospitals.4
In the Terri Schiavo case, the patient’s husband disagreed with the life-sustaining decisions of his wife’s parents given her persistent vegetative state and the fact that she had no chance of meaningful recovery. After a prolonged national debate, it was ultimately decided that the husband could elect to withhold artificial nutrition. (She died in 2005.) The Schiavo case, as well as the Institute of Medicine’s report on “Dying in America,”5 influenced Congress in 2016 to pass legislation funding ACP conversations.
The demonstrated benefits of advance care planning
When done comprehensively, ACP yields many benefits for patients and families and for the health care system. A systematic review demonstrated that, despite the few studies examining the economic cost of ACP, the process may lead to decreased health care costs in certain populations (nursing home residents, community dwelling adults with dementia, and those living in high health care spending regions) and at the very least does not increase health care costs.6 ACP has increased the number of do-not-resuscitate orders7 and has decreased hospitalizations,8 admissions to intensive care units,7,8 and rates of cardiopulmonary resuscitation,7,8 mechanical ventilation,7,8 and use of tube feeding.8
More noteworthy than the decrease in resource utilization and potential cost savings is the impact that ACP can have on a patient’s quality of life. Patients who receive aggressive care at the end of life tend to experience decreased quality of life compared with those receiving hospice care.7 Quality-of-life scores for patients in hospice improved with the length of enrollment in that care.7 When ACP discussions have taken place, the care patients receive at the end of life tends to conform more closely to their wishes and to increase family satisfaction.9-11
One reason that practitioners often give for not completing ACP is the fear of increasing patient or family anxiety or post-traumatic stress disorder (PTSD). However, studies have shown this concern to be unfounded.7,12 While ACP studies have not shown a decrease in rates of anxiety or PTSD, no study has shown an increase in these psychological morbidities.8
Caveats to keep in mind. Not all studies have shown unambiguous benefits related to ACP. Among the systematic reviews previously noted, there was significant variability in quality of data. Additionally, some experts argue that the traditional view of ACP (ie, completion of a single advance directive/living will) is outdated and should be replaced with a method that prepares patients and families to anticipate “in-the-moment decision making.”13 While we still believe that completion of an advance directive is useful, the experts’ point is well taken, especially since many patients change their preferences over time (and typically towards more aggressive care).14,15 While the advance directive serves a role, it is more important to help patients recognize their goals and preferences and to facilitate ongoing discussions between the patient and their families/surrogate decision maker and providers.
A snapshot of participation in advance care planning
Despite the ACP movement and the likely benefits associated with it, most individuals have not participated. Rates of completion do seem to be rising, but there is still room for improvement. Among all individuals older than 18 years, only 26.3% have an advance directive.16 In a cohort of older patients seen in an emergency department, only 40% had a living will, while nearly 54% had a designated health care power of attorney.17 Perhaps more alarming is the lack of ACP for those patients almost all physicians would agree need it—the long-term care population. The National Center for Health Statistics has reported that only 28% of home health care patients, 65% of nursing home residents, and 88% of hospice patients have an advance directive on file.18
Physician and patient barriers to advance care planning
If ACP can decrease resource utilization and improve caregiver compliance with a patient’s wishes for end of life, the obvious question is: Why isn’t it done more often? A longstanding barrier for physicians has been that these types of discussions are time intensive and have not been billable. However, since January 1, 2016, we are now able to bill for these discussions. (More on this in a bit.) Physicians do cite other barriers, though.
A recent systematic review showed that ACP is hindered by time constraints imposed by other clinical and administrative tasks that are heavily monitored.19 Barriers to engaging in ACP reported by patients include a reluctance to think about dying, a belief that family or physicians will know what to do, difficulty understanding ACP forms, and the absence of a person who can serve as a surrogate decision-maker.20,21
There are national models to help with implementation
The percentage of individuals with an advance directive in the United States has not increased significantly over the past decade.22 The lack of traction in completion and use of advance directives has lead several authors to question the utility of this older model of ACP.22 Several experts in the field believe that more robust, ongoing goals-of-care conversations between patients, families, and providers are equally, or even more, important than the completion of actual advance directive documents.23,24
National models such as the POLST (Physician Orders for Life-Sustaining Treatment) paradigm have become popular in several states (http://www.polst.org). Intended for those with estimated life expectancy of less than one year, POLST is not an advance directive but a physician order for these seriously ill patients. Emergency medical service workers are legally able to follow a POLST document but not a living will or advance directive—a significant reason for those with end-stage illness to consider completing a POLST document with their health care provider. Programs such as, “Respecting Choices,” have incorporated POLST documentation as part of ongoing goals-of-care conversations between patients and health care providers (http://www.gundersenhealth.org/respecting-choices).
Many groups have developed products to encourage patients and their families to initiate conversations at home. An example is the Conversation Project, a free online resource available in multiple languages that can help break the ice for patients and get them talking about their wishes for end-of-life care (http://www.theconversationproject.org). It poses simple stimulating questions such as: “What kind of role do you want to have in the decision-making process?” and “What are your concerns about treatment?”
How-to tips for advance care planning in the outpatient setting
When approaching the topic of ACP with patients, it’s important to do so over time, starting as soon as possible with older patients and those with chronic illness conferring a high risk of significant morbidity or mortality. Assess each patient’s understanding of ACP and readiness to discuss the topic. Many patients think of ACP in the context of a document (eg, living will), so asking about the existence of a living will may help to start the conversation. Alternatively, consider inquiring about whether the patient has had experience with family or friends at the end of life or during a difficult medical situation, and whether the patient has thought about making personal plans for such a situation.25
When a patient is ready to have this conversation, your goal should be three-fold: 26
- Help the patient articulate personal values, goals, and preferences.
- Ask the patient
to formally assign health care power of attorney (POA) to a trusted individual or to name a surrogate decision-maker. Document this decision in the medical record. - Help the patient translate expressed values into specific medical care plans, if applicable.
Because ACP conversations are often time consuming, it’s a good idea to schedule separate appointments to focus on this alone. If, however, a patient is unable to return for a dedicated ACP visit, a first step that can be completed in a reasonably short period would be choosing a surrogate decision-maker.
Helping a patient articulate personal values may be eased by asking such questions as: “Have you ever thought about what kind of care you would want if the time came when you could not make your own decisions?” or “What worries you the most about possibly not being able to make your own decisions?”27 If the patient is able to identify a surrogate decision maker before the ACP appointment, ask that this person attend. A family member or close friend may remember instances in which the patient expressed health care preferences, and their presence can help to minimize gaps in communication.
Once the patient’s preferences are clear, document them in the medical record. Some preferences may be suitable for translation into POLST orders or an advance directive, but this is less important than the overall discussion. ACP should be an ongoing conversation, since a patient’s goals may change over time. And encourage the patient to share any desired change in plans with their surrogate decision-
Be sure to bill for advance care planning services
To encourage office-based providers to conduct ACP, CMS implemented payment for CPT codes 99497 and 99498.
CPT code 99497 covers the first 30 minutes of face-to-face time with patients or their family members or medical decision-makers. This time can be used to discuss living wills or advance directives.
CPT code 99498 can be applied to each additional 30 minutes of ACP services. Typically, this billing code would be used as an add-on for a particular diagnosis such as heart failure, chronic obstructive pulmonary disease, or pancreatic cancer.
CPT Code 99497 equates to 2.40 relative-value units (RVU) with an estimated payment of $85.99, while CPT code 99498 equates to 2.09 RVU with an estimated payment of $74.88.28
According to CMS, there is no annual limit to the number of times the ACP codes can be billed for a particular patient. And there are no restrictions regarding location of service, meaning a provider could perform this in an outpatient setting, an inpatient setting, or a long-term care facility. Both physicians and non-physician practitioners are allowed to bill with this code. Also worth noting: You don’t need to complete any particular documentation for a visit to be billed as an ACP service. CMS provides a helpful Q & A at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/Downloads/FAQ-Advance-Care-Planning.pdf.
CORRESPONDENCE
John Liantonio, MD, Thomas Jefferson University Hospital, Department of Family and Community Medicine, 1015 Walnut Street, Suite 401, Philadelphia, PA 19107; john.liantonio@jefferson.edu
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. California Law Revision Commission. 2000 Health Care Decisions Law and Revised Power of Attorney Law. Available at: http://www.clrc.ca.gov/pub/Printed-Reports/Pub208.pdf. Accessed May 15, 2017.
3. H.R. 5067 - 101st Congress. Patient Self Determination Act of 1990. Available at: https://www.govtrack.us/congress/bills/101/hr5067. Accessed November 16, 2016
4. The SUPPORT Principle Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995;274:1591-1598.
5. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: National Academies Press; 2015.
6. Dixon J, Matosevic T, Knapp M. The economic evidence for advance care planning: systematic review of evidence. Palliat Med. 2015;29:869-884.
7. Wright AA, Ray A, Mack JW, et al. Associations between end-of-life discussions, patient mental-health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300:1665-1673.
8. Brinkman-Stoppelenburg A, Rietjens JAC, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28:1000-1025.
9. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.
10. Morrison RS, Chichin E, Carter J, et al. The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc. 2005;53:290-294.
11. Schamp R, Tenkku L. Managed death in a PACE: pathways in present and advance directives. J Am Med Dir Assoc. 2006;7:339-344.
12. Walczak A, Butow PN, Bu S, et al. A systematic review of evidence for end-of-life communication interventions: who do they target, how are they structured and do they work? Patient Educ Couns. 2016;99:3-16.
13. Sudore RL, Fried TR. Redefining the “planning” in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010;153:256-261.
14. Straton JB, Wang NY, Meoni LA, et al. Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors study. J Am Geriatr Soc. 2004;52:577-582.
15. Fried TR, Byers AL, Gallo WT, et al. Prospective study of health status preferences and changes in preferences over time in older adults. Arch Intern Med. 2006;166:890-895.
16. Rao JK, Anderson LA, Lin F, et al. Completion of advance directives among U.S. consumers. Am J Prev Med. 2014;46:65-70.
17. Grudzen CR, Buonocore P, Steinberg J, et al; AAHPM Research Committee Writing Group. Concordance of advance care plans with inpatient directives in the electronic medical record for older patients admitted from the emergency department. J Pain Symptom Manage. 2016;51:647-651.
18. Jones AL, Moss AJ, Harris-Kojetin LD. Use of advance directives in long-term care populations. NCHS Data Brief. 2011;(54):1-8.
19. Lund S, Richardson A, May C. Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies. PLoS One. 2015;10:e0116629.
20. Fried TR, Bullock K, Iannone L, et al. Understanding advance care planning as a process of health behavior change. J Am Geriatr Soc. 2009;57:1547-1555.
21. Schickedanz AD, Schillinger D, Landefeld CS, et al. A clinical framework for improving the advance care planning process: start with patients’ self-identified barriers. J Am Geriatr Soc. 2009;57:31-39.
22. Winter L, Parks SM, Diamond JJ. Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Pall Med. 2010;13:567-572.
23. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Available at: https://www.nap.edu/read/18748/chapter/1. Accessed May 15, 2017.
24. Sudore RL, Schickedanz AD, Landefeld CS, et al. Engagement in multiple steps of the advance care planning process: a descriptive study of diverse older adults. J Am Geriatr Soc. 2008;56:1006-1013.
25. McMahan RD, Knight SJ, Fried TR, et al. Advance care planning beyond advance directives: perspectives from patients and surrogates. J Pain Symptom Manage. 2013;46:355-365.
26. Lum HD, Sudore RL, Bekelman DB. Advance care planning in the elderly. Med Clin North Am. 2015;99:391-403.
27. Lum HD, Sudore RL. Advance care planning and goals of care communication in older adults with cardiovascular disease and multi-morbidity. Clin Geriatr Med. 2016;32:247-260.
28. American College of Physicians. Advanced Care Planning: Implementation for practices. Available at: https://www.acponline.org/system/files/documents/practice-resources/business-resources/payment/advance_care_planning_toolkit.pdf. Accessed May 15, 2017.
With the number of aging Americans projected to grow dramatically in the next several years, the need for primary palliative care and advance care planning (ACP) is more important than ever. Patients and their families want and expect palliative care when needed, but initial conversations about ACP can be difficult for them. Appropriate timing in raising this subject and clear communication can give patients the opportunity, while they are still independent, to set their goals for medical care.
For the past several decades, political decisions and judicial cases have shaped palliative care as we know it today. And its shape is still evolving. In support of ACP, advocacy groups at a national level are developing models that practitioners can use to engage patients in setting goals. And Medicare is now reimbursing primary care providers for this work that they have been doing for years (although many still may not be billing for the service).
Finally, the busy primary care office may have its own set of challenges in addressing ACP. Our aim in this review is to identify the barriers we face and the solutions we can implement to make a difference in our patients’ end-of-life care planning.
[polldaddy:9795119]
Landmark events have defined advance care planning today
In 1969, Luis Kutner, an Illinois attorney, proposed the idea of a “living will,” envisioned as a document specifying the types of treatment a person would be willing to receive were they unable at a later time to participate in making a decision.1 In 1976, California became the first state to give living wills the power of the law through the Natural Death Act.2
Throughout the 1970s and '80s, several high-profile court cases brought this idea into the national spotlight. In 1975, the New Jersey Supreme Court granted the parents of 21-year-old Karen Ann Quinlan the right to discontinue the treatment sustaining her in a persistent vegetative state. Ms. Quinlan was removed from the ventilator and lived 9 more months before dying in a nursing home.
A few years later, Nancy Cruzan, a 32-year-old woman involved in a 1983 motor vehicle accident, was also in a persistent vegetative state and remained so until 1988 when her parents asked that her feeding tube be removed. The hospital refused, indicating that it would lead to her death. The family sued and the case eventually went to the US Supreme Court in 1989.
In a 5-to-4 decision, the Supreme Court ruled that a state was legally able to require “clear and convincing evidence” of a patient’s wish for removal of life-sustaining therapies. Cruzan’s family was able to provide such evidence and her artificial nutrition was withheld. She died 12 days later.
The Cruzan case was instrumental in furthering ACP, leading to the passage of the Patient Self Determination Act (PSDA) by Congress in 1990. All federally funded health care facilities were now required to educate patients of their rights in determining their medical care and to ask about advance directives.3 The ACP movement gained additional momentum from the landmark SUPPORT study that documented shortcomings in communication between physicians and patients/families about treatment preferences and end-of-life care in US hospitals.4
In the Terri Schiavo case, the patient’s husband disagreed with the life-sustaining decisions of his wife’s parents given her persistent vegetative state and the fact that she had no chance of meaningful recovery. After a prolonged national debate, it was ultimately decided that the husband could elect to withhold artificial nutrition. (She died in 2005.) The Schiavo case, as well as the Institute of Medicine’s report on “Dying in America,”5 influenced Congress in 2016 to pass legislation funding ACP conversations.
The demonstrated benefits of advance care planning
When done comprehensively, ACP yields many benefits for patients and families and for the health care system. A systematic review demonstrated that, despite the few studies examining the economic cost of ACP, the process may lead to decreased health care costs in certain populations (nursing home residents, community dwelling adults with dementia, and those living in high health care spending regions) and at the very least does not increase health care costs.6 ACP has increased the number of do-not-resuscitate orders7 and has decreased hospitalizations,8 admissions to intensive care units,7,8 and rates of cardiopulmonary resuscitation,7,8 mechanical ventilation,7,8 and use of tube feeding.8
More noteworthy than the decrease in resource utilization and potential cost savings is the impact that ACP can have on a patient’s quality of life. Patients who receive aggressive care at the end of life tend to experience decreased quality of life compared with those receiving hospice care.7 Quality-of-life scores for patients in hospice improved with the length of enrollment in that care.7 When ACP discussions have taken place, the care patients receive at the end of life tends to conform more closely to their wishes and to increase family satisfaction.9-11
One reason that practitioners often give for not completing ACP is the fear of increasing patient or family anxiety or post-traumatic stress disorder (PTSD). However, studies have shown this concern to be unfounded.7,12 While ACP studies have not shown a decrease in rates of anxiety or PTSD, no study has shown an increase in these psychological morbidities.8
Caveats to keep in mind. Not all studies have shown unambiguous benefits related to ACP. Among the systematic reviews previously noted, there was significant variability in quality of data. Additionally, some experts argue that the traditional view of ACP (ie, completion of a single advance directive/living will) is outdated and should be replaced with a method that prepares patients and families to anticipate “in-the-moment decision making.”13 While we still believe that completion of an advance directive is useful, the experts’ point is well taken, especially since many patients change their preferences over time (and typically towards more aggressive care).14,15 While the advance directive serves a role, it is more important to help patients recognize their goals and preferences and to facilitate ongoing discussions between the patient and their families/surrogate decision maker and providers.
A snapshot of participation in advance care planning
Despite the ACP movement and the likely benefits associated with it, most individuals have not participated. Rates of completion do seem to be rising, but there is still room for improvement. Among all individuals older than 18 years, only 26.3% have an advance directive.16 In a cohort of older patients seen in an emergency department, only 40% had a living will, while nearly 54% had a designated health care power of attorney.17 Perhaps more alarming is the lack of ACP for those patients almost all physicians would agree need it—the long-term care population. The National Center for Health Statistics has reported that only 28% of home health care patients, 65% of nursing home residents, and 88% of hospice patients have an advance directive on file.18
Physician and patient barriers to advance care planning
If ACP can decrease resource utilization and improve caregiver compliance with a patient’s wishes for end of life, the obvious question is: Why isn’t it done more often? A longstanding barrier for physicians has been that these types of discussions are time intensive and have not been billable. However, since January 1, 2016, we are now able to bill for these discussions. (More on this in a bit.) Physicians do cite other barriers, though.
A recent systematic review showed that ACP is hindered by time constraints imposed by other clinical and administrative tasks that are heavily monitored.19 Barriers to engaging in ACP reported by patients include a reluctance to think about dying, a belief that family or physicians will know what to do, difficulty understanding ACP forms, and the absence of a person who can serve as a surrogate decision-maker.20,21
There are national models to help with implementation
The percentage of individuals with an advance directive in the United States has not increased significantly over the past decade.22 The lack of traction in completion and use of advance directives has lead several authors to question the utility of this older model of ACP.22 Several experts in the field believe that more robust, ongoing goals-of-care conversations between patients, families, and providers are equally, or even more, important than the completion of actual advance directive documents.23,24
National models such as the POLST (Physician Orders for Life-Sustaining Treatment) paradigm have become popular in several states (http://www.polst.org). Intended for those with estimated life expectancy of less than one year, POLST is not an advance directive but a physician order for these seriously ill patients. Emergency medical service workers are legally able to follow a POLST document but not a living will or advance directive—a significant reason for those with end-stage illness to consider completing a POLST document with their health care provider. Programs such as, “Respecting Choices,” have incorporated POLST documentation as part of ongoing goals-of-care conversations between patients and health care providers (http://www.gundersenhealth.org/respecting-choices).
Many groups have developed products to encourage patients and their families to initiate conversations at home. An example is the Conversation Project, a free online resource available in multiple languages that can help break the ice for patients and get them talking about their wishes for end-of-life care (http://www.theconversationproject.org). It poses simple stimulating questions such as: “What kind of role do you want to have in the decision-making process?” and “What are your concerns about treatment?”
How-to tips for advance care planning in the outpatient setting
When approaching the topic of ACP with patients, it’s important to do so over time, starting as soon as possible with older patients and those with chronic illness conferring a high risk of significant morbidity or mortality. Assess each patient’s understanding of ACP and readiness to discuss the topic. Many patients think of ACP in the context of a document (eg, living will), so asking about the existence of a living will may help to start the conversation. Alternatively, consider inquiring about whether the patient has had experience with family or friends at the end of life or during a difficult medical situation, and whether the patient has thought about making personal plans for such a situation.25
When a patient is ready to have this conversation, your goal should be three-fold: 26
- Help the patient articulate personal values, goals, and preferences.
- Ask the patient
to formally assign health care power of attorney (POA) to a trusted individual or to name a surrogate decision-maker. Document this decision in the medical record. - Help the patient translate expressed values into specific medical care plans, if applicable.
Because ACP conversations are often time consuming, it’s a good idea to schedule separate appointments to focus on this alone. If, however, a patient is unable to return for a dedicated ACP visit, a first step that can be completed in a reasonably short period would be choosing a surrogate decision-maker.
Helping a patient articulate personal values may be eased by asking such questions as: “Have you ever thought about what kind of care you would want if the time came when you could not make your own decisions?” or “What worries you the most about possibly not being able to make your own decisions?”27 If the patient is able to identify a surrogate decision maker before the ACP appointment, ask that this person attend. A family member or close friend may remember instances in which the patient expressed health care preferences, and their presence can help to minimize gaps in communication.
Once the patient’s preferences are clear, document them in the medical record. Some preferences may be suitable for translation into POLST orders or an advance directive, but this is less important than the overall discussion. ACP should be an ongoing conversation, since a patient’s goals may change over time. And encourage the patient to share any desired change in plans with their surrogate decision-
Be sure to bill for advance care planning services
To encourage office-based providers to conduct ACP, CMS implemented payment for CPT codes 99497 and 99498.
CPT code 99497 covers the first 30 minutes of face-to-face time with patients or their family members or medical decision-makers. This time can be used to discuss living wills or advance directives.
CPT code 99498 can be applied to each additional 30 minutes of ACP services. Typically, this billing code would be used as an add-on for a particular diagnosis such as heart failure, chronic obstructive pulmonary disease, or pancreatic cancer.
CPT Code 99497 equates to 2.40 relative-value units (RVU) with an estimated payment of $85.99, while CPT code 99498 equates to 2.09 RVU with an estimated payment of $74.88.28
According to CMS, there is no annual limit to the number of times the ACP codes can be billed for a particular patient. And there are no restrictions regarding location of service, meaning a provider could perform this in an outpatient setting, an inpatient setting, or a long-term care facility. Both physicians and non-physician practitioners are allowed to bill with this code. Also worth noting: You don’t need to complete any particular documentation for a visit to be billed as an ACP service. CMS provides a helpful Q & A at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/Downloads/FAQ-Advance-Care-Planning.pdf.
CORRESPONDENCE
John Liantonio, MD, Thomas Jefferson University Hospital, Department of Family and Community Medicine, 1015 Walnut Street, Suite 401, Philadelphia, PA 19107; john.liantonio@jefferson.edu
With the number of aging Americans projected to grow dramatically in the next several years, the need for primary palliative care and advance care planning (ACP) is more important than ever. Patients and their families want and expect palliative care when needed, but initial conversations about ACP can be difficult for them. Appropriate timing in raising this subject and clear communication can give patients the opportunity, while they are still independent, to set their goals for medical care.
For the past several decades, political decisions and judicial cases have shaped palliative care as we know it today. And its shape is still evolving. In support of ACP, advocacy groups at a national level are developing models that practitioners can use to engage patients in setting goals. And Medicare is now reimbursing primary care providers for this work that they have been doing for years (although many still may not be billing for the service).
Finally, the busy primary care office may have its own set of challenges in addressing ACP. Our aim in this review is to identify the barriers we face and the solutions we can implement to make a difference in our patients’ end-of-life care planning.
[polldaddy:9795119]
Landmark events have defined advance care planning today
In 1969, Luis Kutner, an Illinois attorney, proposed the idea of a “living will,” envisioned as a document specifying the types of treatment a person would be willing to receive were they unable at a later time to participate in making a decision.1 In 1976, California became the first state to give living wills the power of the law through the Natural Death Act.2
Throughout the 1970s and '80s, several high-profile court cases brought this idea into the national spotlight. In 1975, the New Jersey Supreme Court granted the parents of 21-year-old Karen Ann Quinlan the right to discontinue the treatment sustaining her in a persistent vegetative state. Ms. Quinlan was removed from the ventilator and lived 9 more months before dying in a nursing home.
A few years later, Nancy Cruzan, a 32-year-old woman involved in a 1983 motor vehicle accident, was also in a persistent vegetative state and remained so until 1988 when her parents asked that her feeding tube be removed. The hospital refused, indicating that it would lead to her death. The family sued and the case eventually went to the US Supreme Court in 1989.
In a 5-to-4 decision, the Supreme Court ruled that a state was legally able to require “clear and convincing evidence” of a patient’s wish for removal of life-sustaining therapies. Cruzan’s family was able to provide such evidence and her artificial nutrition was withheld. She died 12 days later.
The Cruzan case was instrumental in furthering ACP, leading to the passage of the Patient Self Determination Act (PSDA) by Congress in 1990. All federally funded health care facilities were now required to educate patients of their rights in determining their medical care and to ask about advance directives.3 The ACP movement gained additional momentum from the landmark SUPPORT study that documented shortcomings in communication between physicians and patients/families about treatment preferences and end-of-life care in US hospitals.4
In the Terri Schiavo case, the patient’s husband disagreed with the life-sustaining decisions of his wife’s parents given her persistent vegetative state and the fact that she had no chance of meaningful recovery. After a prolonged national debate, it was ultimately decided that the husband could elect to withhold artificial nutrition. (She died in 2005.) The Schiavo case, as well as the Institute of Medicine’s report on “Dying in America,”5 influenced Congress in 2016 to pass legislation funding ACP conversations.
The demonstrated benefits of advance care planning
When done comprehensively, ACP yields many benefits for patients and families and for the health care system. A systematic review demonstrated that, despite the few studies examining the economic cost of ACP, the process may lead to decreased health care costs in certain populations (nursing home residents, community dwelling adults with dementia, and those living in high health care spending regions) and at the very least does not increase health care costs.6 ACP has increased the number of do-not-resuscitate orders7 and has decreased hospitalizations,8 admissions to intensive care units,7,8 and rates of cardiopulmonary resuscitation,7,8 mechanical ventilation,7,8 and use of tube feeding.8
More noteworthy than the decrease in resource utilization and potential cost savings is the impact that ACP can have on a patient’s quality of life. Patients who receive aggressive care at the end of life tend to experience decreased quality of life compared with those receiving hospice care.7 Quality-of-life scores for patients in hospice improved with the length of enrollment in that care.7 When ACP discussions have taken place, the care patients receive at the end of life tends to conform more closely to their wishes and to increase family satisfaction.9-11
One reason that practitioners often give for not completing ACP is the fear of increasing patient or family anxiety or post-traumatic stress disorder (PTSD). However, studies have shown this concern to be unfounded.7,12 While ACP studies have not shown a decrease in rates of anxiety or PTSD, no study has shown an increase in these psychological morbidities.8
Caveats to keep in mind. Not all studies have shown unambiguous benefits related to ACP. Among the systematic reviews previously noted, there was significant variability in quality of data. Additionally, some experts argue that the traditional view of ACP (ie, completion of a single advance directive/living will) is outdated and should be replaced with a method that prepares patients and families to anticipate “in-the-moment decision making.”13 While we still believe that completion of an advance directive is useful, the experts’ point is well taken, especially since many patients change their preferences over time (and typically towards more aggressive care).14,15 While the advance directive serves a role, it is more important to help patients recognize their goals and preferences and to facilitate ongoing discussions between the patient and their families/surrogate decision maker and providers.
A snapshot of participation in advance care planning
Despite the ACP movement and the likely benefits associated with it, most individuals have not participated. Rates of completion do seem to be rising, but there is still room for improvement. Among all individuals older than 18 years, only 26.3% have an advance directive.16 In a cohort of older patients seen in an emergency department, only 40% had a living will, while nearly 54% had a designated health care power of attorney.17 Perhaps more alarming is the lack of ACP for those patients almost all physicians would agree need it—the long-term care population. The National Center for Health Statistics has reported that only 28% of home health care patients, 65% of nursing home residents, and 88% of hospice patients have an advance directive on file.18
Physician and patient barriers to advance care planning
If ACP can decrease resource utilization and improve caregiver compliance with a patient’s wishes for end of life, the obvious question is: Why isn’t it done more often? A longstanding barrier for physicians has been that these types of discussions are time intensive and have not been billable. However, since January 1, 2016, we are now able to bill for these discussions. (More on this in a bit.) Physicians do cite other barriers, though.
A recent systematic review showed that ACP is hindered by time constraints imposed by other clinical and administrative tasks that are heavily monitored.19 Barriers to engaging in ACP reported by patients include a reluctance to think about dying, a belief that family or physicians will know what to do, difficulty understanding ACP forms, and the absence of a person who can serve as a surrogate decision-maker.20,21
There are national models to help with implementation
The percentage of individuals with an advance directive in the United States has not increased significantly over the past decade.22 The lack of traction in completion and use of advance directives has lead several authors to question the utility of this older model of ACP.22 Several experts in the field believe that more robust, ongoing goals-of-care conversations between patients, families, and providers are equally, or even more, important than the completion of actual advance directive documents.23,24
National models such as the POLST (Physician Orders for Life-Sustaining Treatment) paradigm have become popular in several states (http://www.polst.org). Intended for those with estimated life expectancy of less than one year, POLST is not an advance directive but a physician order for these seriously ill patients. Emergency medical service workers are legally able to follow a POLST document but not a living will or advance directive—a significant reason for those with end-stage illness to consider completing a POLST document with their health care provider. Programs such as, “Respecting Choices,” have incorporated POLST documentation as part of ongoing goals-of-care conversations between patients and health care providers (http://www.gundersenhealth.org/respecting-choices).
Many groups have developed products to encourage patients and their families to initiate conversations at home. An example is the Conversation Project, a free online resource available in multiple languages that can help break the ice for patients and get them talking about their wishes for end-of-life care (http://www.theconversationproject.org). It poses simple stimulating questions such as: “What kind of role do you want to have in the decision-making process?” and “What are your concerns about treatment?”
How-to tips for advance care planning in the outpatient setting
When approaching the topic of ACP with patients, it’s important to do so over time, starting as soon as possible with older patients and those with chronic illness conferring a high risk of significant morbidity or mortality. Assess each patient’s understanding of ACP and readiness to discuss the topic. Many patients think of ACP in the context of a document (eg, living will), so asking about the existence of a living will may help to start the conversation. Alternatively, consider inquiring about whether the patient has had experience with family or friends at the end of life or during a difficult medical situation, and whether the patient has thought about making personal plans for such a situation.25
When a patient is ready to have this conversation, your goal should be three-fold: 26
- Help the patient articulate personal values, goals, and preferences.
- Ask the patient
to formally assign health care power of attorney (POA) to a trusted individual or to name a surrogate decision-maker. Document this decision in the medical record. - Help the patient translate expressed values into specific medical care plans, if applicable.
Because ACP conversations are often time consuming, it’s a good idea to schedule separate appointments to focus on this alone. If, however, a patient is unable to return for a dedicated ACP visit, a first step that can be completed in a reasonably short period would be choosing a surrogate decision-maker.
Helping a patient articulate personal values may be eased by asking such questions as: “Have you ever thought about what kind of care you would want if the time came when you could not make your own decisions?” or “What worries you the most about possibly not being able to make your own decisions?”27 If the patient is able to identify a surrogate decision maker before the ACP appointment, ask that this person attend. A family member or close friend may remember instances in which the patient expressed health care preferences, and their presence can help to minimize gaps in communication.
Once the patient’s preferences are clear, document them in the medical record. Some preferences may be suitable for translation into POLST orders or an advance directive, but this is less important than the overall discussion. ACP should be an ongoing conversation, since a patient’s goals may change over time. And encourage the patient to share any desired change in plans with their surrogate decision-
Be sure to bill for advance care planning services
To encourage office-based providers to conduct ACP, CMS implemented payment for CPT codes 99497 and 99498.
CPT code 99497 covers the first 30 minutes of face-to-face time with patients or their family members or medical decision-makers. This time can be used to discuss living wills or advance directives.
CPT code 99498 can be applied to each additional 30 minutes of ACP services. Typically, this billing code would be used as an add-on for a particular diagnosis such as heart failure, chronic obstructive pulmonary disease, or pancreatic cancer.
CPT Code 99497 equates to 2.40 relative-value units (RVU) with an estimated payment of $85.99, while CPT code 99498 equates to 2.09 RVU with an estimated payment of $74.88.28
According to CMS, there is no annual limit to the number of times the ACP codes can be billed for a particular patient. And there are no restrictions regarding location of service, meaning a provider could perform this in an outpatient setting, an inpatient setting, or a long-term care facility. Both physicians and non-physician practitioners are allowed to bill with this code. Also worth noting: You don’t need to complete any particular documentation for a visit to be billed as an ACP service. CMS provides a helpful Q & A at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/Downloads/FAQ-Advance-Care-Planning.pdf.
CORRESPONDENCE
John Liantonio, MD, Thomas Jefferson University Hospital, Department of Family and Community Medicine, 1015 Walnut Street, Suite 401, Philadelphia, PA 19107; john.liantonio@jefferson.edu
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. California Law Revision Commission. 2000 Health Care Decisions Law and Revised Power of Attorney Law. Available at: http://www.clrc.ca.gov/pub/Printed-Reports/Pub208.pdf. Accessed May 15, 2017.
3. H.R. 5067 - 101st Congress. Patient Self Determination Act of 1990. Available at: https://www.govtrack.us/congress/bills/101/hr5067. Accessed November 16, 2016
4. The SUPPORT Principle Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995;274:1591-1598.
5. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: National Academies Press; 2015.
6. Dixon J, Matosevic T, Knapp M. The economic evidence for advance care planning: systematic review of evidence. Palliat Med. 2015;29:869-884.
7. Wright AA, Ray A, Mack JW, et al. Associations between end-of-life discussions, patient mental-health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300:1665-1673.
8. Brinkman-Stoppelenburg A, Rietjens JAC, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28:1000-1025.
9. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.
10. Morrison RS, Chichin E, Carter J, et al. The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc. 2005;53:290-294.
11. Schamp R, Tenkku L. Managed death in a PACE: pathways in present and advance directives. J Am Med Dir Assoc. 2006;7:339-344.
12. Walczak A, Butow PN, Bu S, et al. A systematic review of evidence for end-of-life communication interventions: who do they target, how are they structured and do they work? Patient Educ Couns. 2016;99:3-16.
13. Sudore RL, Fried TR. Redefining the “planning” in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010;153:256-261.
14. Straton JB, Wang NY, Meoni LA, et al. Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors study. J Am Geriatr Soc. 2004;52:577-582.
15. Fried TR, Byers AL, Gallo WT, et al. Prospective study of health status preferences and changes in preferences over time in older adults. Arch Intern Med. 2006;166:890-895.
16. Rao JK, Anderson LA, Lin F, et al. Completion of advance directives among U.S. consumers. Am J Prev Med. 2014;46:65-70.
17. Grudzen CR, Buonocore P, Steinberg J, et al; AAHPM Research Committee Writing Group. Concordance of advance care plans with inpatient directives in the electronic medical record for older patients admitted from the emergency department. J Pain Symptom Manage. 2016;51:647-651.
18. Jones AL, Moss AJ, Harris-Kojetin LD. Use of advance directives in long-term care populations. NCHS Data Brief. 2011;(54):1-8.
19. Lund S, Richardson A, May C. Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies. PLoS One. 2015;10:e0116629.
20. Fried TR, Bullock K, Iannone L, et al. Understanding advance care planning as a process of health behavior change. J Am Geriatr Soc. 2009;57:1547-1555.
21. Schickedanz AD, Schillinger D, Landefeld CS, et al. A clinical framework for improving the advance care planning process: start with patients’ self-identified barriers. J Am Geriatr Soc. 2009;57:31-39.
22. Winter L, Parks SM, Diamond JJ. Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Pall Med. 2010;13:567-572.
23. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Available at: https://www.nap.edu/read/18748/chapter/1. Accessed May 15, 2017.
24. Sudore RL, Schickedanz AD, Landefeld CS, et al. Engagement in multiple steps of the advance care planning process: a descriptive study of diverse older adults. J Am Geriatr Soc. 2008;56:1006-1013.
25. McMahan RD, Knight SJ, Fried TR, et al. Advance care planning beyond advance directives: perspectives from patients and surrogates. J Pain Symptom Manage. 2013;46:355-365.
26. Lum HD, Sudore RL, Bekelman DB. Advance care planning in the elderly. Med Clin North Am. 2015;99:391-403.
27. Lum HD, Sudore RL. Advance care planning and goals of care communication in older adults with cardiovascular disease and multi-morbidity. Clin Geriatr Med. 2016;32:247-260.
28. American College of Physicians. Advanced Care Planning: Implementation for practices. Available at: https://www.acponline.org/system/files/documents/practice-resources/business-resources/payment/advance_care_planning_toolkit.pdf. Accessed May 15, 2017.
1. Kutner L. Due process of euthanasia: the living will, a proposal. Indiana Law J. 1969;44:539-554.
2. California Law Revision Commission. 2000 Health Care Decisions Law and Revised Power of Attorney Law. Available at: http://www.clrc.ca.gov/pub/Printed-Reports/Pub208.pdf. Accessed May 15, 2017.
3. H.R. 5067 - 101st Congress. Patient Self Determination Act of 1990. Available at: https://www.govtrack.us/congress/bills/101/hr5067. Accessed November 16, 2016
4. The SUPPORT Principle Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995;274:1591-1598.
5. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: National Academies Press; 2015.
6. Dixon J, Matosevic T, Knapp M. The economic evidence for advance care planning: systematic review of evidence. Palliat Med. 2015;29:869-884.
7. Wright AA, Ray A, Mack JW, et al. Associations between end-of-life discussions, patient mental-health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300:1665-1673.
8. Brinkman-Stoppelenburg A, Rietjens JAC, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28:1000-1025.
9. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.
10. Morrison RS, Chichin E, Carter J, et al. The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc. 2005;53:290-294.
11. Schamp R, Tenkku L. Managed death in a PACE: pathways in present and advance directives. J Am Med Dir Assoc. 2006;7:339-344.
12. Walczak A, Butow PN, Bu S, et al. A systematic review of evidence for end-of-life communication interventions: who do they target, how are they structured and do they work? Patient Educ Couns. 2016;99:3-16.
13. Sudore RL, Fried TR. Redefining the “planning” in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010;153:256-261.
14. Straton JB, Wang NY, Meoni LA, et al. Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors study. J Am Geriatr Soc. 2004;52:577-582.
15. Fried TR, Byers AL, Gallo WT, et al. Prospective study of health status preferences and changes in preferences over time in older adults. Arch Intern Med. 2006;166:890-895.
16. Rao JK, Anderson LA, Lin F, et al. Completion of advance directives among U.S. consumers. Am J Prev Med. 2014;46:65-70.
17. Grudzen CR, Buonocore P, Steinberg J, et al; AAHPM Research Committee Writing Group. Concordance of advance care plans with inpatient directives in the electronic medical record for older patients admitted from the emergency department. J Pain Symptom Manage. 2016;51:647-651.
18. Jones AL, Moss AJ, Harris-Kojetin LD. Use of advance directives in long-term care populations. NCHS Data Brief. 2011;(54):1-8.
19. Lund S, Richardson A, May C. Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies. PLoS One. 2015;10:e0116629.
20. Fried TR, Bullock K, Iannone L, et al. Understanding advance care planning as a process of health behavior change. J Am Geriatr Soc. 2009;57:1547-1555.
21. Schickedanz AD, Schillinger D, Landefeld CS, et al. A clinical framework for improving the advance care planning process: start with patients’ self-identified barriers. J Am Geriatr Soc. 2009;57:31-39.
22. Winter L, Parks SM, Diamond JJ. Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Pall Med. 2010;13:567-572.
23. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Available at: https://www.nap.edu/read/18748/chapter/1. Accessed May 15, 2017.
24. Sudore RL, Schickedanz AD, Landefeld CS, et al. Engagement in multiple steps of the advance care planning process: a descriptive study of diverse older adults. J Am Geriatr Soc. 2008;56:1006-1013.
25. McMahan RD, Knight SJ, Fried TR, et al. Advance care planning beyond advance directives: perspectives from patients and surrogates. J Pain Symptom Manage. 2013;46:355-365.
26. Lum HD, Sudore RL, Bekelman DB. Advance care planning in the elderly. Med Clin North Am. 2015;99:391-403.
27. Lum HD, Sudore RL. Advance care planning and goals of care communication in older adults with cardiovascular disease and multi-morbidity. Clin Geriatr Med. 2016;32:247-260.
28. American College of Physicians. Advanced Care Planning: Implementation for practices. Available at: https://www.acponline.org/system/files/documents/practice-resources/business-resources/payment/advance_care_planning_toolkit.pdf. Accessed May 15, 2017.
PRACTICE RECOMMENDATIONS
› Schedule visits dedicated to advance care planning (ACP) to remove time barriers and ensure that ACP is completed. C
› Give priority to identifying a health care representative. C
› Bill Centers for Medicare and Medicaid Services (CMS) for primary care ACP visits with CPT codes 99497 and 99498. Most private insurers are following CMS recommendations. C
Strength of recommendation (SOR)
A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series
Case Management Improves Quality of Life for Cancer Survivors
After cancer treatment, a new challenge emerges as patients negotiate reentry into their everyday lives. These patients often need multifaceted, simultaneous, and ongoing help with physical, emotional, and psychological issues. And they’re often dealing with a multiplicity of health care providers.
Researchers from University of Zurich and Centres for Addiction Medicine in Zurich, Switzerland, saw similarities between these needs and those of patients with chronic medical conditions. They hypothesized that case management—like that for chronic diseases—could work for cancer survivors perhaps even better than usual care. Among other duties, case managers can assess individual needs, identify barriers, ensure coordination among care providers, and perhaps most important, promote empowering self-management skills and self-efficacy. All of which could help cancer survivors cope with the long-term consequences of cancer and improve health-related quality of life (QOL).
Related: Putting the Focus on Quality of Life in Cancer Care
The researchers designed an intervention study in which 5 oncology nurse case managers met with 95 patients at least once a month for 3 months, then conducted telephone follow-ups for 9 months. Questionnaires measured health-related QOL at 12 months via the Functional Assessment of Cancer Therapy-General (FACT-G), self-efficacy, and concordance of received care with the Patient Assessment of Chronic Illness Care (PACIC).
Although the researchers’ study did not show a significant absolute difference between the groups in FACT-G after 12 months, all scores improved in the case management group compared with the usual care group. Overall, case management clearly boosted QOL and self-efficacy and aligned health care with the chronic care model.
Related: Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA
According to the researchers, their study is the first, to their knowledge, to examine the effect of case management on the QOL of early cancer survivors. Several factors help explain the intervention’s success: (1) The case managers provided important information on long-term symptoms and available services and therapies; (2) They offered a continuity of care when treatment appointments ceased and medical follow-up visits were less frequent; and (3) They offered support to cope with the psychological issues of the reentry phase.
All in all, the researchers say their findings show case management is a practical approach to bridging a “fragmented oncological health care system” and addressing the heterogenic needs of cancer survivors.
Source:
Scherz N, Bachmann-Mettler I, Chmiel C. BMC Cancer. 2017;17(1):223.
doi: 10.1186/s12885-017-3213-9.
After cancer treatment, a new challenge emerges as patients negotiate reentry into their everyday lives. These patients often need multifaceted, simultaneous, and ongoing help with physical, emotional, and psychological issues. And they’re often dealing with a multiplicity of health care providers.
Researchers from University of Zurich and Centres for Addiction Medicine in Zurich, Switzerland, saw similarities between these needs and those of patients with chronic medical conditions. They hypothesized that case management—like that for chronic diseases—could work for cancer survivors perhaps even better than usual care. Among other duties, case managers can assess individual needs, identify barriers, ensure coordination among care providers, and perhaps most important, promote empowering self-management skills and self-efficacy. All of which could help cancer survivors cope with the long-term consequences of cancer and improve health-related quality of life (QOL).
Related: Putting the Focus on Quality of Life in Cancer Care
The researchers designed an intervention study in which 5 oncology nurse case managers met with 95 patients at least once a month for 3 months, then conducted telephone follow-ups for 9 months. Questionnaires measured health-related QOL at 12 months via the Functional Assessment of Cancer Therapy-General (FACT-G), self-efficacy, and concordance of received care with the Patient Assessment of Chronic Illness Care (PACIC).
Although the researchers’ study did not show a significant absolute difference between the groups in FACT-G after 12 months, all scores improved in the case management group compared with the usual care group. Overall, case management clearly boosted QOL and self-efficacy and aligned health care with the chronic care model.
Related: Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA
According to the researchers, their study is the first, to their knowledge, to examine the effect of case management on the QOL of early cancer survivors. Several factors help explain the intervention’s success: (1) The case managers provided important information on long-term symptoms and available services and therapies; (2) They offered a continuity of care when treatment appointments ceased and medical follow-up visits were less frequent; and (3) They offered support to cope with the psychological issues of the reentry phase.
All in all, the researchers say their findings show case management is a practical approach to bridging a “fragmented oncological health care system” and addressing the heterogenic needs of cancer survivors.
Source:
Scherz N, Bachmann-Mettler I, Chmiel C. BMC Cancer. 2017;17(1):223.
doi: 10.1186/s12885-017-3213-9.
After cancer treatment, a new challenge emerges as patients negotiate reentry into their everyday lives. These patients often need multifaceted, simultaneous, and ongoing help with physical, emotional, and psychological issues. And they’re often dealing with a multiplicity of health care providers.
Researchers from University of Zurich and Centres for Addiction Medicine in Zurich, Switzerland, saw similarities between these needs and those of patients with chronic medical conditions. They hypothesized that case management—like that for chronic diseases—could work for cancer survivors perhaps even better than usual care. Among other duties, case managers can assess individual needs, identify barriers, ensure coordination among care providers, and perhaps most important, promote empowering self-management skills and self-efficacy. All of which could help cancer survivors cope with the long-term consequences of cancer and improve health-related quality of life (QOL).
Related: Putting the Focus on Quality of Life in Cancer Care
The researchers designed an intervention study in which 5 oncology nurse case managers met with 95 patients at least once a month for 3 months, then conducted telephone follow-ups for 9 months. Questionnaires measured health-related QOL at 12 months via the Functional Assessment of Cancer Therapy-General (FACT-G), self-efficacy, and concordance of received care with the Patient Assessment of Chronic Illness Care (PACIC).
Although the researchers’ study did not show a significant absolute difference between the groups in FACT-G after 12 months, all scores improved in the case management group compared with the usual care group. Overall, case management clearly boosted QOL and self-efficacy and aligned health care with the chronic care model.
Related: Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA
According to the researchers, their study is the first, to their knowledge, to examine the effect of case management on the QOL of early cancer survivors. Several factors help explain the intervention’s success: (1) The case managers provided important information on long-term symptoms and available services and therapies; (2) They offered a continuity of care when treatment appointments ceased and medical follow-up visits were less frequent; and (3) They offered support to cope with the psychological issues of the reentry phase.
All in all, the researchers say their findings show case management is a practical approach to bridging a “fragmented oncological health care system” and addressing the heterogenic needs of cancer survivors.
Source:
Scherz N, Bachmann-Mettler I, Chmiel C. BMC Cancer. 2017;17(1):223.
doi: 10.1186/s12885-017-3213-9.